Neuroimmune interactions in respiratory syncytial virus-infected airways
- 1 May 2002
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 21 (5) , 462-467
- https://doi.org/10.1097/00006454-200205000-00034
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Respiratory Syncytial Virus and Parainfluenza VirusNew England Journal of Medicine, 2001
- Exaggerated Neurogenic Inflammation and Substance P Receptor Upregulation in RSV-Infected Weanling RatsAmerican Journal of Respiratory Cell and Molecular Biology, 2001
- A Humanized Monoclonal Antibody against Respiratory Syncytial Virus (Palivizumab) Inhibits RSV-Induced Neurogenic-Mediated Inflammation in Rat AirwaysPediatric Research, 2000
- Variability of Airway Responses in MiceLung, 1999
- Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 yearsThe Lancet, 1999
- Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial VirusThe Journal of Infectious Diseases, 1997
- Neurogenic Amplification of Immune Complex InflammationScience, 1996
- Tachykinin Peptides, Receptors, and Peptidases in Airway DiseaseExperimental Lung Research, 1995
- Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cellsJournal of Neurocytology, 1988
- Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitisThe Journal of Pediatrics, 1986